Skip to main content

Market Overview

311
Articles
68K
Views

Vandana Singh

Benzinga Staff Writer

March 02, 2021 11:34 AM
The FDA has classified another recall of Medtronic Plc's (NYSE: MDT) HeartWare HVAD ventricular assist device as a Class ...
March 02, 2021 11:18 AM
AbbVie Inc (NYSE: ABBV) has landed an option to buy Mitokinin upon completing IND-enabling studies on the latter's lead PINK1 ...
March 02, 2021 9:12 AM
U.S. President Joe Biden will announce that Merck & Co (NYSE: MRK) will help manufacture its rival Johnson & Johnson&rsquo ...
March 02, 2021 8:57 AM
Strongbridge Biopharma plc (NASDAQ: SBBP) has submitted a marketing application seeking approval for Recorlev (levoketoconazole) for the treatme ...
March 02, 2021 8:53 AM
Neurocrine Biosciences Inc (NASDAQ: NBIX) announces topline data from Phase 2 INTERACT study evaluating luvadaxistat (NBI-1065844/ ...
March 02, 2021 8:47 AM
Cerecor Inc (NASDAQ: CERC) shares gained premarket on the heels of final efficacy data, including 60-day mortality from the Phase ...
March 02, 2021 8:44 AM
Reports of allergic reactions to Pfizer Inc (NYSE: PFE) and Moderna Inc (NASDAQ: MRNA) vaccines are not very common, wit ...
March 02, 2021 8:36 AM
The FDA has accepted Oyster Point Pharma Inc's (NASDAQ: OYST) marketing application for review. It seeks approval for OC-01 ( ...
March 02, 2021 8:32 AM
Johnson & Johnson (NYSE: JNJ) is waiting on regulatory approval of a new, larger plant operated by Catalent Inc (NYS ...
March 02, 2021 5:51 AM
A recent study revealed that one dose of either Pfizer Inc (NYSE: PFE)/BioNtech SE (NASDAQ: BNTX) or Oxford-AstraZeneca Plc&n ...
March 02, 2021 5:40 AM
The FDA has accepted for review Argenx SE's (NASDAQ: ARGX) marketing application seeking approval for intravenous (IV) efgarti ...
March 02, 2021 5:15 AM
Novavax Inc’s (NASDAQ: NVAX) COVID-19 shot can probably win FDA emergency use nod as early as May, said the company’s CEO Stanle ...
March 01, 2021 1:11 PM
Annexon Inc (NASDAQ: ANNX) has commenced patient dosing in its Phase 2 ARCHER study evaluating ANX007 to treat Geographi ...
March 01, 2021 1:03 PM
Ocular Therapeutix Inc (NASDAQ: OCUL) has dosed the first patient in its Phase 2 trial evaluating OTX-DED (dexamethasone intracana ...